Elidah

Focus: Elidah is a newly founded (2024) medical device company focused on pelvic floor stimulation devices for urinary incontinence and related disorders. The company operates as a public entity from Connecticut with a highly specialized, narrow product focus.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Elidah

AI assessmentNot Hiring

No open roles listed right now. Follow Elidah to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

4 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

ELITONE UUI

Urge Incontinence

N/A

Clinical Trials (1)

NCT04752709Efficacy of Surface Electrical Stimulation for Urge Urinary Incontinence in Women

N/A

Help build intelligence for Elidah

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage company founded in 2024 offers ground-floor opportunity to build organizational infrastructure and establish career trajectory within a focused medical device segment
Portfolio addresses underserved pelvic floor disorders market with four distinct device modalities, providing clinical depth and multiple revenue streams potential
Public company status suggests access to capital and exit visibility, though specific funding details are unavailable

Watch Out For

Company is pre-revenue with no active job postings (0 roles listed), indicating either extreme early stage or potential organizational constraint
Extremely limited data transparency: no employee count, funding amount, ticker, or revenue metrics available, making career growth and stability assessment impossible
Four active clinical trials across multiple indications but no defined phases (all listed as N/A) suggests early-stage, unvalidated pipeline with uncertain timeline to commercialization

Generated by Claude from Elidah's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Transcutaneous electrical stimulation

Stress Urinary Incontinence

N/A

Clinical Trials (1)

NCT03782116Stress Incontinence Trial With Elitone Device

N/A

Perineal-applied electrical stimulation

Urinary Incontinence

N/A

Clinical Trials (1)

NCT06620419Clinical Study of External Electrical Stimulation for Male Incontinence

N/A

Surface electrical stimulation

Pelvic Floor Disorders

N/A

Clinical Trials (1)

NCT03528928Viewing Surface Electrical Stimulation on Pelvic Floor With Ultrasound

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2024

Portfolio: 4 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo